Proteomics in antitumor research

Riccardo Alessandro; Simona Fontana; Sandra Kraljevic Pavelic; Mirela Sedic

Proteomics in antitumor research

Riccardo Alessandro, Simona Fontana, Sandra Kraljevic Pavelic, Mirela Sedic

Biomedicina, Neuroscienze e Diagnostica avanzata

Risultato della ricerca: Article › peer review

8 Citazioni (Scopus)

Abstract

Proteins are the molecular players of fine-tuned regulatorypathways that underlie the behavior of any celltype. Derangement of this wide protein circuitry has aprofound effect on cell life and ultimately contributesto the development of diseases such as cancer. Newproteomic technologies are rapidly evolving to defineand characterize the nodes of this altered protein network,both inside and outside cancer cells. Hopefully,these technologies will become user-friendly laboratorytools to improve cancer management from earlydetection to the development of rational and patienttailoredtherapeutic strategies.

Lingua originale	English
pagine (da-a)	441-449
Numero di pagine	9
Rivista	Drug Discovery Today
Volume	3
Stato di pubblicazione	Published - 2006

All Science Journal Classification (ASJC) codes

Molecular Medicine
Drug Discovery

Altri file e collegamenti

OA Link

Fingerprint Entra nei temi di ricerca di 'Proteomics in antitumor research'. Insieme formano una fingerprint unica.

Cita questo

@article{7f5834ec4aed464a9c60c00f854af6b7,

title = "Proteomics in antitumor research",

abstract = "Proteins are the molecular players of fine-tuned regulatorypathways that underlie the behavior of any celltype. Derangement of this wide protein circuitry has aprofound effect on cell life and ultimately contributesto the development of diseases such as cancer. Newproteomic technologies are rapidly evolving to defineand characterize the nodes of this altered protein network,both inside and outside cancer cells. Hopefully,these technologies will become user-friendly laboratorytools to improve cancer management from earlydetection to the development of rational and patienttailoredtherapeutic strategies.",

author = "Riccardo Alessandro and Simona Fontana and {Kraljevic Pavelic}, Sandra and Mirela Sedic",

year = "2006",

language = "English",

volume = "3",

pages = "441--449",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Proteomics in antitumor research

AU - Alessandro, Riccardo

AU - Fontana, Simona

AU - Kraljevic Pavelic, Sandra

AU - Sedic, Mirela

PY - 2006

Y1 - 2006

N2 - Proteins are the molecular players of fine-tuned regulatorypathways that underlie the behavior of any celltype. Derangement of this wide protein circuitry has aprofound effect on cell life and ultimately contributesto the development of diseases such as cancer. Newproteomic technologies are rapidly evolving to defineand characterize the nodes of this altered protein network,both inside and outside cancer cells. Hopefully,these technologies will become user-friendly laboratorytools to improve cancer management from earlydetection to the development of rational and patienttailoredtherapeutic strategies.

AB - Proteins are the molecular players of fine-tuned regulatorypathways that underlie the behavior of any celltype. Derangement of this wide protein circuitry has aprofound effect on cell life and ultimately contributesto the development of diseases such as cancer. Newproteomic technologies are rapidly evolving to defineand characterize the nodes of this altered protein network,both inside and outside cancer cells. Hopefully,these technologies will become user-friendly laboratorytools to improve cancer management from earlydetection to the development of rational and patienttailoredtherapeutic strategies.

UR - http://hdl.handle.net/10447/14383

M3 - Article

VL - 3

SP - 441

EP - 449

JO - Drug Discovery Today

JF - Drug Discovery Today

SN - 1359-6446

ER -